Literature DB >> 10036640

Tyrosine phosphorylated proteins in synovial cells of rheumatoid arthritis.

T Takeuchi1, T Abe.   

Abstract

Two of the key events in the pathogenesis of rheumatoid arthritis are the synovial cell proliferation and lymphocyte infiltration into the synovium. The resulting synovitis is longlasting and leads to destructive arthritis, which is a hallmark of rheumatoid arthritis. Accumulating evidence suggests that one of the key biochemical events in the altered cell function of RA is phosphorylation of the tyrosine residues of proteins. In this paper we review the cellular components participating in the chronic inflammation of RA joints. We present the results of analyzing tyrosine phosphorylated proteins of synovial cells from RA patients and discuss a possible pathogenic role of non-receptor tyrosine kinase in RA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10036640     DOI: 10.3109/08830189809054411

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  3 in total

1.  Association of rheumatoid arthritis risk with EGFR genetic polymorphisms in Taiwan's Han Chinese population.

Authors:  Sui-Foon Lo; Lei Wan; Hsiu-Chen Lin; Chung-Ming Huang; Shih-Yin Chen; Su-Ching Liu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2011-05-21       Impact factor: 2.631

2.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

3.  Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients.

Authors:  Shoji Yamane; Satoru Ishida; Yukie Hanamoto; Ken-Ichi Kumagai; Riako Masuda; Konagi Tanaka; Noriyuki Shiobara; Noriko Yamane; Toshihito Mori; Takuo Juji; Naoshi Fukui; Tsunetoshi Itoh; Takahiro Ochi; Ryuji Suzuki
Journal:  J Inflamm (Lond)       Date:  2008-04-27       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.